Universal Health Services Stock Forecast

Stock Price Forecast

According to 20 analysts polled by S&P Global, Universal Health Services stock has a consensus rating of "Buy" and an average price target of $193.65. The average 1-year stock price forecast is 12.12% higher than the current stock price, while the lowest is $166 (-3.89%) and the highest is $290 (+67.90%).

Price Target: $193.65 (+12.12%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$166	$193.65	$191	$290
Change	-3.89%	+12.12%	+10.58%	+67.90%

Analyst Ratings

The average analyst rating for Universal Health Services stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	6	6	6	6	6	6
Buy	2	2	2	1	1	1
Hold	10	11	11	12	12	12
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	19	20	20	20	20	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stephen Baxter Wells Fargo	Wells Fargo	Hold Maintains $166	Hold	Maintains	$166	-3.89%	Sep 9, 2026
Benjamin Rossi J.P. Morgan	J.P. Morgan	Hold Maintains $200	Hold	Maintains	$200	+15.79%	Sep 4, 2026
A.J. Rice UBS	UBS	Buy Reiterates $290	Buy	Reiterates	$290	+67.90%	Aug 31, 2026
Ben Hendrix RBC Capital	RBC Capital	Hold Maintains $183	Hold	Maintains	$183	+5.95%	Aug 20, 2026
Kevin Fischbeck Bank of America Securities	Bank of America Securities	Sell Reiterates $162 → $170	Sell	Reiterates	$162 → $170	-1.57%	Aug 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

18.61B

from 17.36B

7.15%

from 17.36B

Revenue Next Year

19.50B

from 18.61B

4.79%

from 18.61B

EPS This Year

22.53

from 21.74

3.62%

from 21.74

EPS Next Year

24.02

from 22.53

6.62%

from 22.53

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	12.64B	13.40B	14.28B	15.83B	17.36B	18.61B
Revenue Growth	9.37%	5.99%	6.59%	10.83%	9.71%	7.15%
Gross Profit	5.05B	5.16B	5.64B	6.72B	7.62B	7.55B
Gross Margin	39.95%	38.53%	39.50%	42.47%	43.89%	40.60%
Operating Income	1.39B	1.06B	1.18B	1.68B	1.99B	2.01B
Net Income	991.59M	675.61M	717.80M	1.14B	1.49B	1.35B
EPS	-	-	-	-	21.74	22.53
EPS Growth	-	-	-	-	30.89%	3.62%
Forward PE	11.02	13.12	13.40	10.33	9.45	7.67
Dividend / Share	0.80	0.80	0.80	0.80	0.80	0.83
Dividend Growth	300.00%	-	-	-	-	3.40%
Free Cash Flow	281.23M	124.84M	310.62M	956.54M	565.25M	999.00M
No. Analysts	-	-	-	-	-	17

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	18.9B
Avg	18.6B
Low	18.4B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	8.9%
Avg	7.1%
Low	5.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	23.50
Avg	22.53
Low	20.68

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	8.1%
Avg	3.6%
Low	-4.9%